Related by context. All words. (Click for frequent words.) 90 dyskinesia PD LID 81 allosteric modulator NAM 78 mGluR5 negative 74 PEGylated anti 73 methylnaltrexone bromide 72 oral prodrug 72 Safinamide 71 mGluR2 positive 71 PD LID 71 mGluR5 NAM 71 TNF Tumor Necrosis Factor 70 diarrhea predominant irritable 70 Meets Primary Endpoint 69 Methylnaltrexone 69 diarrhea fatigue asthenia 69 PEGylated Fab fragment 69 Phase Ib clinical trials 69 Serostim ® 69 Phase 2b Clinical Trial 69 Disease IBD 69 Phase IIb Trial 69 ELADUR TM 69 DDP# 69 R Saizen R 69 SABER ™ 69 Initiate Phase 69 Tezampanel 69 sapropterin dihydrochloride 69 intranasal formulation 68 Personalized Immunotherapy 68 non nucleoside inhibitor 68 virus HCV protease inhibitor 68 albiglutide 68 toenail onychomycosis 68 mu opioid receptor antagonist 68 peripherally acting 68 refractory gout 68 dihydrochloride 68 Trial Evaluating 68 dihydrochloride Tablets 68 R lenalidomide 68 Initiates Phase II 68 selective modulator 68 TO AVOID PREGNANCY WHILE 68 vapreotide acetate 68 cromolyn sodium 68 FDA APPROVES 68 AVE# 68 Cannabinor 68 pseudobulbar affect PBA 67 Eculizumab 67 dependent kinase inhibitor 67 aripiprazole Abilify 67 huC# DM4 67 Augment TM 67 Lubiprostone 67 TLK# 67 docetaxel Taxotere ® 67 Study Evaluating 67 novel VDA molecule 67 nephropathic cystinosis 67 dextromethorphan quinidine 67 Orally administered 67 abacavir sulfate lamivudine 67 Wafer polifeprosan 67 Receives Orphan Drug Designation 67 Microplasmin 67 Excellarate TM 67 Zorbtive TM 67 overactive bladder AA# 67 ELADUR ™ 67 indinavir Crixivan 67 myelodysplastic myeloproliferative diseases 67 CYT# potent vascular disrupting 67 Initiates Enrollment 67 ergot derivatives 67 acute peripheral arterial 67 FOLOTYN ® 67 R roscovitine CDK cyclin 67 dasatinib Sprycel ® 67 oral dual endothelin 67 lamotrigine Lamictal 67 Aflibercept 67 Sciences ABthrax Albuferon 67 receptor tyrosine kinase inhibitor 67 neuropathic pain spasticity 67 fumarate 67 ocular formulation 66 beta 1a 66 nucleoside analog 66 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 66 II Clinical Trial 66 headache nasopharyngitis 66 fosbretabulin 66 JAK inhibitor 66 mertansine 66 SAR# [002] 66 targeted radiotherapeutic 66 CHEAP ONLINE PHARMACY LOW 66 INSPIRE Trial Phase III 66 sapropterin dihydrochloride Tablets 66 PNP inhibitor 66 familial amyloidotic polyneuropathy FAP 66 Completes Patient Enrollment 66 interferon beta 1a infertility 66 evaluating tivozanib 66 ADX# 66 itraconazole Sporanox 66 Pegylated 66 CB2 selective receptor agonist 66 BCG refractory carcinoma 66 Copegus ® 66 PEGASYS ® 66 Pharmacokinetics PK 66 sunitinib Sutent ® 66 6R BH4 66 Hsp# Inhibitor 66 TELINTRA 66 pralatrexate injection folate analogue 66 Pegloticase 66 pan histone deacetylase 66 Recombinant Human 66 cell lymphoma CTCL 66 pan HDAC inhibitor 66 catheter occlusion 66 lexidronam injection 66 Novel Oral 66 Adenoscan R 66 erlotinib Tarceva ® 66 Pafuramidine 66 Randomized Double blind 66 AAG geldanamycin analog 66 MKC# MKC# PP 66 selective A2A adenosine receptor 66 First Patient Dosed 66 allosteric modulator PAM 66 CYP#A# CYP#D# 66 PKC# 66 aldehyde dehydrogenase ALDH2 deficiency 66 dihydroergotamine 66 Combination REOLYSIN R 66 iobenguane 66 TRANSDUR ™ 66 polymerase inhibitor 66 topically applied SEPA 66 hypereosinophilic syndrome 66 orally administered inhibitor 66 hyperphenylalaninemia HPA due 66 selective antagonist 66 Phase III Trial 66 AVAPRO 66 XL# anticancer compounds 66 LymphoStat B TM 66 D aspartate NMDA receptor 66 Oral Fingolimod 66 trastuzumab Herceptin R 66 Granted Orphan Drug 66 Nitazoxanide 66 Golimumab 66 somatropin Kuvan R 66 DURIN TM 66 acetonide FA 66 oral nucleoside analogue 65 rHuPH# recombinant human 65 PRN FDA Approves 65 pathophysiological effects 65 dexlansoprazole 65 OMNARIS HFA 65 Drug Candidate 65 Inhalation Aerosol 65 TRANSDUR ® 65 occlusion PAO 65 Phase 2a Clinical Trial 65 cardiometabolic diseases Glucophage 65 Traficet EN 65 BUPHENYL 65 Solazed ™ 65 sorafenib tablets 65 Dapagliflozin 65 generation purine nucleoside 65 Tolvaptan 65 Elagolix 65 topical gel formulation 65 ALVESCO 65 Prodarsan R 65 Ribavirin causes 65 systemic juvenile idiopathic 65 Initiates Clinical Trial 65 Clolar ® 65 HGS ETR1 mapatumumab 65 MKC# MT 65 administered subcutaneously 65 CHEAP ONLINE PHARMACY BEST 65 ritonavir boosted 65 rusalatide acetate 65 refractory chronic lymphocytic 65 Serostim R 65 PEGINTRON TM 65 prokinetic agent 65 hyaluronidase enzyme 65 Gel repository corticotropin injection 65 INCB# [003] 65 Solazed TM 65 Ovitrelle R Serostim 65 Mg Uk 65 Luteinizing Hormone Releasing Hormone 65 NS5B polymerase 65 Naive Patients 65 iloprost synthetic compound 65 Sudhir Agrawal D.Phil 65 Oral Suspension Oral Suspension 65 CDK inhibitor 65 rasagiline tablets 65 ABLYNX 65 TNF alpha selectively neutralizing 65 targeting Inflammatory Bowel 65 Cetrorelix 65 humanized interleukin 6 65 sodium thiosulfate STS 65 inhaled formulation 65 Completes Enrollment 65 small molecule thrombopoietin 65 Pivotal Phase 65 developing Bicifadine serotonin 65 Initiates Clinical 65 Atripla combines 65 Kuvan TM sapropterin 65 Phase 2b Trial 65 oropharyngeal candidiasis OPC 65 cetuximab Erbitux R 65 CCR5 mAb 65 PRICE GREAT DISCOUNT FREE 65 rivastigmine Exelon 65 Copegus R 65 myelofibrosis polycythemia vera 65 bevacizumab Avastin R 65 brand ciclesonide HFA 65 Seliciclib CYC# 65 IL# PE#QQR 65 epoetin delta 65 ALN HPN 65 Refractory Peripheral T 65 formerly LymphoStat B 65 NASH Huntington 65 adenosine injection 65 cannabinor 65 Peginterferon alfa 2a 65 Albuferon TM 65 IAP inhibitor 65 Pivotal Phase III 65 histone deacetylase HDAC inhibitor 65 2A receptor agonist 65 cutaneous T 65 REPRONEX R menotropins 65 selective androgen receptor modulator 64 human C1 inhibitor 64 potent CYP#A# inhibitors 64 By JENNIFER LEARN 64 Phase III Clinical Trial 64 Veronate R 64 acyclovir Lauriad R 64 humanized anti 64 oral proteasome inhibitor 64 long acting muscarinic 64 Demonstrates Positive 64 molecular imaging radiopharmaceutical 64 Ambrisentan 64 injection USP 64 metabolic disorders Saizen R 64 Coadministration 64 Oral NKTR 64 REPRONEX ® menotropins 64 essential thrombocythemia ET 64 Pegasys ® 64 ACTEMRA TM 64 Xcytrin R 64 INCB# [001] 64 Zenvia ™ 64 Phase IIa Clinical Trial 64 Archexin 64 Kinase Inhibitor 64 weekly subcutaneous injections 64 MAGE A3 ASCI 64 Investigational Treatment 64 sodium glucose cotransporter 64 Presents Positive 64 investigational humanized monoclonal antibody 64 Kuvan R 64 Vitrasert R 64 multicenter Phase III 64 LymphoStat B belimumab 64 MCSP respectively 64 ACTIQ ® 64 SinuNase TM 64 GATTEX ™ 64 hypertrichosis occurred 64 opioid bowel dysfunction 64 Initiate Clinical Trial 64 2 methoxyestradiol 64 AEG# 64 Phase IIb Clinical Trial 64 Neulasta R 64 humanized monoclonal 64 samarium Sm 64 benzoic acid hyoscyamine sulfate 64 dexpramipexole 64 Diffuse Large B 64 Frozen Shoulder syndrome Adhesive 64 Pancreas Cancer Vaccine 64 VIVITROL ® 64 forodesine 64 Zemiva ™ 64 ADL# novel 64 Clinical Trial Results 64 R bendamustine hydrochloride 64 selective phosphodiesterase 64 octreotide acetate 64 phenyl salicylate methylene blue 64 Granulocyte Colony Stimulating Factor 64 therapeutically inactive prodrug 64 opioid induced constipation OIC 64 phase III isavuconazole 64 Leukine ® 64 Iloperidone 64 Kuvan sapropterin dihydrochloride 64 Saizen ® 64 Phase III Pivotal 64 Achieves Primary Endpoint 64 phenylketonuria PKU developed 64 sodium benzoate prescription 64 Xeloda ® 64 highly selective inhibitor 64 Vaprisol 64 IMiDs ® 64 Vicriviroc 64 bone marrow reticulin deposition 64 treat chronic sinusitis 64 vaginal candidiasis 64 FEMALES SHOULD BE ADVISED 64 kidney urologic 64 negative allosteric modulator 64 Sapacitabine 64 Iluvien ® 64 imatinib Gleevec ® 64 Randomized Phase 64 Adalimumab 64 Mg Usa 64 Nabi HB ® 64 docetaxel Taxotere R 64 5 FU leucovorin 64 ZOMIG 64 diabetic neuropathic pain 64 Solution XOPENEX HFA 64 systemic RNAi therapeutic 64 ciprofloxacin hydrochloride 64 RhuDex ® 64 trial evaluating PRX# 64 Complicated Skin 64 alfa 2a 64 Onalta ™ 64 ® lenalidomide 64 R bisoprolol Euthyrox 64 Palifosfamide 64 Dose Ranging Study 64 pioglitazone HCl 64 chronic eosinophilic leukemia 64 hormone LHRH antagonist 64 valtorcitabine 64 factor TNF receptor 64 phase IIb clinical 64 monoclonal antibody conjugated 64 injection purified MENOPUR 64 ramipril Altace 64 bowel syndrome 64 Phase 2a Trial 64 Aurora Kinase 64 CD# CEA 64 arthritis PsA 64 CIMZIA R 64 systemically administered 64 reslizumab 64 Presents Preclinical Data 64 opioid induced bowel dysfunction 64 orally inhaled 64 hypoxia activated prodrug 64 Humanized Anti 64 metastatic malignant 64 Phase 2b Study 64 zonisamide SR 64 arsenic trioxide injection 64 administered concomitantly 64 Aurexis R 64 NOTE POSIDUR ™ 64 CEQ# 64 IN PATIENTS WITH 64 Inhalation Powder 64 Initiated Phase 64 FUSILEV ® 64 Bosutinib 64 Entereg R 64 Presents Preclinical 64 combines bupropion 64 Omacetaxine mepesuccinate 64 TRO# 64 orally administered synthetic retinoid 64 transthyretin TTR mediated amyloidosis 64 monoclonal anti 64 EDEMA3 64 mesylate 64 GTC recombinant human 64 systemic anaplastic large 64 erythematosus SLE 63 GW# [003] 63 5 HT6 receptor 63 non alcoholic steatohepatitis 63 Immune Globulin Human 63 INVANZ 63 R metformin Concor 63 Pivotal Study 63 fentanyl buccal tablet 63 post herpetic neuralgia PHN 63 N acetylgalactosamine 6 63 sorafenib Nexavar 63 delivers fluocinolone acetonide FA 63 proteasome inhibitor 63 pegylated recombinant 63 ORENCIA ® 63 complement inhibitor eculizumab 63 Begins Dosing 63 Familial Adenomatous Polyposis FAP 63 ® famotidine 63 KRN# 63 constipation predominant irritable bowel 63 Advancing Drugs 63 investigational pan BCR 63 abacavir Ziagen 63 TRX1 63 CTAP# Injection 63 include PLX IBD 63 METOZOLV TM ODT metoclopramide 63 Zenvia TM 63 non constipating irritable 63 posaconazole 63 candesartan cilexetil 63 Receives Orphan Drug 63 ALN TTR# 63 Initiates Phase 63 antibody MAb 63 receptor partial agonist 63 protein tyrosine phosphatase 1B 63 Ecallantide 63 Ropinirole 63 soluble tumor necrosis 63 SPRYCEL ® 63 highly purified pasteurized 63 Capesaris 63 mitoxantrone plus 63 Injectable Bone Graft 63 PDE4 inhibitor 63 NGX# 63 bleeding pallor 63 idiopathic thrombocytopenic purpura ITP 63 Certolizumab pegol 63 HuMax EGFr 63 Telik logo TELINTRA 63 pediatric Crohn disease 63 Fludara ® 63 XP# XP# 63 oral Janus kinase 63 Pimavanserin 63 generation antisense inhibitor 63 Fx #A 63 MT# MEDI 63 polyneuropathy HIV DSP 63 WX UK1 63 Gonal f R follitropin 63 RoACTEMRA 63 PRICES GREAT DISCOUNTS 63 Antitumor Activity 63 Randomized Double Blind Placebo 63 baminercept 63 Transdermal Patch 63 Refractory Hodgkin Lymphoma 63 thalidomide Thalomid 63 benign prostatic hypertrophy BPH 63 Intravenous Human 63 TMC# C# 63 vitreoretinal disorders 63 Mylan Receives Approval 63 #-# rDNA origin 63 liposome injection 63 intravesical infusion therapy 63 leukemia AML 63 oral rivaroxaban 63 ospemifene 63 Files IND 63 metaglidasen 63 Phase IIIb 63 positive allosteric modulator 63 IMPDH inhibitor 63 novel synthetic peptide 63 lintuzumab SGN 63 RhuDex 63 Phase 2a Study 63 topical non steroidal 63 Initiates Phase III 63 alvespimycin 63 MOVIPREP R 63 nanofiltered plasma derived 63 BRIM2 63 p# inhibitor 63 rheumatoid arthritis psoriatic arthritis 63 Aclidinium 63 peptidic compound 63 Phase IIa trial 63 Panzem R 63 ADP receptor antagonist 63 rheumatoid arthritis RA psoriatic 63 Horizant ™ 63 Eluting Stent 63 BARACLUDE R 63 rNAPc2 63 treat opioid induced 63 GAMMAGARD 63 Pivotal Trial 63 Alfacell proprietary ribonuclease 63 generation Hsp# inhibitor 63 ® tiagabine hydrochloride 63 class anticancer quinolone 63 MEK inhibitor 63 Alinia 63 Patients Treated With 63 Ostarine ™ 63 Lenocta TM 63 volociximab 63 Darinaparsin 63 Restoraderm R 63 TELINTRA R 63 Ozarelix 63 FOLFOX6 chemotherapy regimen 63 BEST ONLINE PHARMACY LOWEST 63 ® adefovir dipivoxil 63 lucinactant 63 terfenadine 63 Romidepsin 63 candidate AQ4N 63 TRANSDUR TM 63 NMDA antagonist 63 alpha interferons 63 Homspera TM 63 evaluating picoplatin 63 visilizumab 63 lanreotide 63 bevacizumab Avastin ® 63 Phase IIa 63 candidates Azedra TM 63 KNS # 63 diabetic gastroparesis 63 JOULFERON 63 efalizumab 63 phenylalanine ammonia lyase 63 R#/MEM # 63 metastatic neuroendocrine tumors 63 HCV NS5B polymerase 63 ALN PCS 63 candidates Augment ™ 63 injectable formulation 63 PDX pralatrexate 63 post herpetic 63 Laquinimod 63 Preclinical Data 63 JAK2 inhibitor 63 Telithromycin 63 AzaSite Plus 63 C1 Inhibitor 63 AWAY FROM WINDOWS 63 Factor VIIa 63 Vascular Disrupting Agent 63 Friedreich Ataxia FRDA 63 ORENCIA R 63 Linagliptin 63 modulator SERM 63 Lixivaptan 63 Successfully Completes Phase 63 Phase 2a clinical 63 TRIOLEX HE# APOPTONE HE# 63 Epivir R 63 Multiple Ascending Dose 63 rheumatoid arthritis osteoarthritis ankylosing 63 ALN TTR 63 orally inhaled migraine 63 IgG1 63 Anidulafungin 63 Tasimelteon 63 Luveris R Ovidrel R 63 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 63 Omacetaxine 63 inhibitor RG# 63 multicenter Phase II 63 administered intranasally 63 dopamine receptor agonist 63 VISICOL R 63 ropinirole Requip 62 THAT ARE NOT SENT 62 phase IIa 62 intravenously administered 62 ALVESCO ® 62 refractory cutaneous T 62 Inhalation Solution 62 Phase Ib study 62 drug pipeline TAFA# 62 Irinotecan 62 Aryplase 62 Dupuytren Disease 62 Tocilizumab 62 PET FROM 62 product platforms AZX# 62 AFREZZA TM 62 GSK# [002] 62 CORT # 62 bexarotene 62 albinterferon alfa 2b 62 Kit CD# positive 62 Aztreonam lysine 62 Solzira TM 62 ALVESCO R 62 miconazole Lauriad ® 62 induced mucositis 62 DOXIL R 62 Ocrelizumab 62 receptor inhibitor 62 5 fluorouracil leucovorin 62 ketolide antibiotic 62 FORWARD LOOKING STATEMENTS INVOLVE 62 Dalbavancin 62 postoperative ileus 62 Onalta 62 pegylated 62 * olmesartan medoxomil 62 GLPG# 62 orally bioavailable 62 IMiDs R 62 FASLODEX 62 TELCYTA 62 GVAX ® 62 Proquin XR 62 Cleviprex TM clevidipine 62 NS#/#A protease 62 erythematosus 62 Certolizumab 62 tiapamil 62 delivery polymer matrix 62 Romiplostim 62 PEG PAL PEGylated recombinant 62 SCH # 62 peritumoral brain edema 62 interferon gamma 1b 62 Submits NDA 62 immunomodulatory therapy 62 modified glutathione analog 62 Uricase PEG 62 PRT# 62 LibiGel ® 62 Diovan Exforge Tekturna Zelnorm 62 cisplatin gemcitabine 62 cMET 62 investigational pharmacologically unique 62 Acute Attacks 62 constipation OIC 62 Gonal f ® 62 SPL# Gel vaginal microbicide 62 Maribavir 62 Epothilone D 62 Metastatic Melanoma 62 Crofelemer budesonide foam 62 severe gastroparesis 62 Mycophenolate Mofetil 62 headache abdominal pain 62 candidate XP# 62 demonstrated antitumor activity 62 THR beta agonist 62 hereditary emphysema 62 IMiDs ® compound 62 INTEGRILIN R 62 Akt inhibitor 62 Sodium oxybate 62 PEGylated interferon beta 1a 62 hPTH #-# 62 Denufosol 62 humanized therapeutic 62 antibody MT# 62 retinal vein occlusion induced 62 TRANSFORMS 62 investigational oral inhibitor 62 Phase IIb trials 62 HYVISC ® treatment 62 Cardium Therapeutics TM 62 vinca alkaloid 62 AMMONUL R sodium phenylacetate 62 Interferon beta 1a 62 INVEGA ® 62 Therapeutic Competitors Companies 62 pegylated interferons 62 budesonide foam 62 receiving INTRON 62 novel synthetic PEGylated 62 Voreloxin 62 Pruvel ™ 62 GATTEX TM 62 selective immunoproteasome inhibitor 62 pentadentate logo R 62 targeted antifolate 62 novel histone deacetylase 62 Investigational Oral 62 Through Glycoscience 62 Fc fusion protein 62 diabetic peripheral neuropathic DPN 62 POSIDUR ™ 62 Controlled Trial 62 pharmacodynamic profile 62 Hypoactive Sexual Desire Disorder 62 Soriatane R 62 Prodarsan ® 62 cytomegalovirus immune globulin 62 quetiapine fumarate 62 Myelodysplastic Syndrome MDS 62 Medoxomil 62 include Phenoptin TM 62 Tibotec Therapeutics division 62 YONDELIS R 62 class mGluR5 inhibitor 62 PRTX 62 cyclobenzaprine hydrochloride extended 62 REVLIMID lenalidomide 62 novel topoisomerase 62 Long Term Efficacy 62 Warner Chilcott Actonel 62 opioid induced constipation 62 COVER YOUR BODY 62 Nebulized 62 5 HT1A receptor 62 polysaccharide polymer 62 tetracycline antibiotic 62 PROCTOCORT R 62 CDP# 62 Lodotra TM 62 Ganciclovir 62 Belimumab 62 Peginterferon alfa 2b 62 HQK 62 either acutely decompensated 62 Daclizumab 62 Tesetaxel 62 Silodosin 62 non splenectomized 62 BENLYSTA ® 62 IS FOR INFORMATIONAL 62 SIDE EFFECTS CHEAP ONLINE 62 Itraconazole 62 Enzyme Replacement Therapy 62 gets USFDA nod 62 transthyretin mediated amyloidosis ATTR 62 pharmacodynamic properties 62 ceftazidime 62 R rilonacept Injection 62 somatostatin analog 62 sublingual tablet formulation 62 topically administered 62 etanercept Enbrel 62 intravesical instillation 62 equine osteoarthritis marketed 62 Gleevec resistant 62 syndrome overactive bladder 62 memantine HCl 62 IV FENTORA R 62 tartrate Inhalation Solution 62 Sym# 62 prescription laxative 62 ODT metoclopramide HCl PEPCID 62 metformin HCl 62 Aviptadil 62 Monotherapy 62 Phase 2a clinical trials 62 inhibitor PPI 62 RANK Ligand inhibitor 62 HuMax HepC TM 62 HuCAL PLATINUM ® CysDisplay 62 active comparator 62 pouchitis 62 HCl PEPCID ® famotidine 62 VYVANSE TM lisdexamfetamine 62 FUSILEV enhances 62 antisense inhibitors 62 Ceflatonin R 62 Known hypersensitivity 62 ABILIFY ® 62 Janus kinase 62 RELISTOR ® 62 HMG CoA reductase inhibitors 62 LB# [003] 62 JZP 62 JAK2 Inhibitor 62 Ofatumumab 62 abacavir lamivudine 62 severe hypersensitivity reactions 62 somatostatin analogue 62 gastrointestinal disorders ATI 62 migraine prophylaxis 62 Mipomersen 62 p# MAP kinase inhibitor 62 LEVADEX TM 62 relapsing remitting MS RRMS 62 BY ERIN MURPHY 62 QLT# 62 markets Gelclair R 62 markets HP Acthar 62 esomeprazole Nexium 62 TBC# 62 NASDAQ CGEN announced 62 Spiegelmer ® 62 RISKS UNCERTAINTIES AND OTHER 62 HCl Tablets 62 Phenoptin 62 post operative ileus 62 Zemiva TM 62 zolmitriptan 62 Ixabepilone 62 Paliperidone Palmitate 62 TPI ASM8 62 lead Aganocide compound 62 alvimopan 62 octreotide implant 62 Phase Ib clinical 62 rabeprazole 62 taxane resistant 62 ATL# [002] 62 UPLYSO 62 Seliciclib 62 experimental autoimmune encephalomyelitis 62 Phase Ib IIa 62 Peginterferon 62 STELARA TM 62 registrational Phase 62 Tanespimycin 62 interferon alfacon 1 61 essential thrombocythemia 61 Pradefovir 61 anti inflammatory NSAID 61 CIMZIA TM certolizumab pegol 61 ferumoxytol Injection 61 humanized monoclonal antibody 61 Bucindolol 61 acne impetigo 61 RNAi Therapeutic 61 non resectable metastatic 61 zileuton 61 Novolimus 61 lexidronam injection PROSTASCINT 61 AVONEX ® 61 Cytogen marketed 61 NDA Submission 61 ZOLINZA 61 Epratuzumab 61 pregabalin Lyrica 61 GEM OS2 61 GLYX 61 includes TOLAMBA TM 61 ZALBIN 61 Phase #b/#a clinical 61 Levoleucovorin 61 HCV protease inhibitor 61 IIa Clinical Trial 61 cetuximab Erbitux ® 61 HuMax CD4 61 hyperplasia BPH 61 polyglutamate 61 Phase 2a 61 Pegasys R 61 lenalidomide Revlimid R 61 candidates Azedra 61 MT#/MEDI-# 61 carcinoid syndrome 61 YONDELIS 61 CysDisplay R 61 chimeric monoclonal antibody 61 injectable investigational 61 treatment naïve genotype 61 mcg QD 61 PHX# 61 oropharyngeal candidiasis 61 included exfoliative dermatitis 61 Amrubicin 61 Kepivance 61 multicenter randomized double 61 echinocandin 61 IMPORTANT FACTORS THAT COULD 61 davunetide intranasal AL 61 Guanilib 61 Sphingomab TM 61 Ranolazine 61 amprenavir 61 tazobactam 61 PROCTOCORT R Suppository Hydrocortisone 61 ulcerative colitis Crohn disease 61 pegylated interferon alfa 2a 61 signal detection CTSD 61 Obatoclax 61 Dasatinib 61 MetroGel 61 DIURIL R 61 ziprasidone Geodon 61 Radezolid 61 Namenda ® 61 Xanafide 61 Opterone R 61 potent topoisomerase II 61 telomerase therapeutic 61 SYN# 61 FK# 61 BUPHENYL R sodium phenylbutyrate 61 HCV RNA polymerase 61 oral dihydropyrimidine dehydrogenase DPD 61 2 inhibitor CYT# 61 investigational monoclonal antibody 61 Endologix Powerlink System 61 beclomethasone dipropionate 61 aerosolized AAT 61 Shows Statistically Significant 61 Cimzia ® certolizumab pegol 61 Simulect 61 Pathway Inhibitor 61 fluticasone furoate 61 ARICEPT R 61 luteinizing hormone releasing 61 Commences Phase 61 adenosine A2A 61 Besivance 61 treat male hypogonadism 61 Files Investigational 61 TACI Ig 61 therefore therapeutically equivalent 61 histone deacetylase inhibitor 61 multicenter randomized placebo controlled 61 phase IIb trial 61 thiazolides 61 Rhucin ® recombinant 61 Cimzia certolizumab pegol 61 salmeterol inhalation powder 61 SUPPRELIN R LA 61 prucalopride 61 Angiotensin Converting Enzyme 61 CTAP# Capsules 61 DECISION WITH RESPECT TO 61 oncolytic virus therapies 61 fluoroquinolone class 61 HCD# [002] 61 Pharmacokinetic Study 61 Milnacipran 61 microtubule inhibitor 61 Eltrombopag 61 HDAC Inhibitor 61 polycythemia vera essential thrombocythemia 61 anti amnesic 61 Testosterone MDTS ® 61 midstage clinical 61 Polyneuropathy 61 By JAMAAL ABDUL 61 product candidate Lpathomab 61 Trodusquemine 61 tumor xenograft models 61 modafinil Tablets C 61 DU #b 61 Immunotherapeutic 61 EXPAREL TM 61 induced macular edema 61 KSP inhibitor 61 CG# [003] 61 PEG SN# 61 PROSTASCINT R 61 lead molecular radiotherapeutic 61 liposomal formulation 61 Saizen R 61 lidocaine hydrochloride monohydrate powder 61 Bone Graft 61 nitric oxide donating prostaglandin 61 IBS C 61 anti CD3 monoclonal 61 Cariprazine 61 Patient Enrollment 61 controlled dose escalation 61 Ophena TM 61 candidates bavituximab 61 R PEG uricase 61 thetreatment 61 nilotinib Tasigna 61 VELCADE melphalan 61 MAP# 61 alpha 2b 61 Multimeric